Jan Mol | Patient Advocate
Hematon

CV: JAN A. MOL, PhD (www.uu.nl/staff/jamol) UNIVERSITY OF UTRECHT, LYMPHOMA COALITION Jan Mol is a retired cell biologist of Utrecht University and patient advocate for people with various forms of blood cancer. Jan Mol graduated from Wageningen University (Molecular Sciences) and did his PhD at Erasmus University Rotterdam on thyroid hormone metabolism. Thereafter he became principal investigator at Utrecht University in the field of endocrinology, oncology and functional genomics of companion animals. He was project leader of the program on Comparative and Translational Oncology which is part of the Regenerative Medicine program of Utrecht Life Sciences. 
After being cured from an aggressive diffuse large B-cell lymphoma (DLBCL) he became board member and patient advocate for Stichting Hematon and the global lymphoma coalition. Nowadays Jan Mol is member of the supervisory board of Hematon, member of the advisory boards of the Dutch Cancer Society KWF and Oncode Accelerator, patient expert for EMA and member of the stakeholdernetwotk of the EU-HTA. His passion is that the patients of today and tomorrow have faster access to truly effective medicines at a socially acceptable price. https://orcid.org/0000-0002-0843-8088